Probability of negative Mycobacterium tuberculosis complex cultures based on time to detection of positive cultures: A multicenter evaluation of commercial-broth-based culture systems

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3275-3282

  Tyrrell, Frances C ^a   Budnick, Gary E ^b   Elliott, Thor ^c   Gillim Ross, Laura ^d   Hildred, Mary V ^e   Mahlmeister, Peggy ^f   Parrish, Nicole ^g   Pentella, Michael ^h   Vanneste, Jolene ⁱ   Wang, Yun F ^j   Starks, Angela M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CDC   (United States)

^c KANSAS DEPARTMENT OF HEALTH AND ENVIRONMENT   (United States)

^d Colorado Department of Public Health and Environment ^*  (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; FOLLOW UP; INCUBATION TIME; INFORMATION PROCESSING; INOCULATION; LABORATORY DEVICE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PUBLIC HEALTH;

AUTOMATION; BACTERIOLOGICAL TECHNIQUES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TIME FACTORS; TUBERCULOSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84866443261     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01225-12     Document Type: Article

References (36)

1. Alcaide F, Benitez MA, Escriba JM, Martin R. 2000. Evaluation of the BACTEC MGIT 960 and the MB/BacT Systems for recovery of mycobacteria from clinical specimens and for species identification by DNA Accu-Probe. J. Clin. Microbiol. 38:398-401. (Pubitemid 30043325)
2. American Thoracic Society Centers for Disease Control and Infectious Diseases Society of America. 2003. Treatment of tuberculosis. Morb. Mortal. Wkly. Rep. 52(RR11):1-77.
3. American Thoracic Society Centers for Disease Control and Prevention and Infectious Diseases Society of America. 2000. Diagnostic standards and classification of tuberculosis in adults and children. Am. J. Respir. Crit. Care Med. 161(Pt 1):1376-1395.
4. Association of Public Health Laboratories. 2009. Mycobacterium tuberculosis: assessing your laboratory. Association of Public Health Laboratories, Silver Spring, MD.
5. Becton Dickinson. 2010. BBL MGIT 7-ml tube package insert. Becton Dickinson and Company, Sparks, MD.
6. bioMerieux. 2008. BacT/ALERT MP package insert, p 1. bioMerieux, Durham, NC.
7. Centers for Disease Control and Prevention. 2011. Chapter 8, community tuberculosis control, p 227. Core curriculum on tuberculosis: what the clinician should know, 5th ed. CDC, Atlanta, GA.
8. Centers for Disease Control and Prevention. 1999. Self study module 6: contact investigations for tuberculosis. CDC, Atlanta, GA.
9. Centers for Disease Control and Prevention. 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 58:7-10.
10. Centers for Disease Control and Prevention Division of Global Migration and Quarantine. 2009. International adoption: health guidance and the immigration process. CDC, Atlanta, GA.
11. Centers for Disease Control and Prevention Division of Global Migration and Quarantine. 2009. Technical instructions for tuberculosis screening and treatment, p 7. In Technical instructions for panel physicians. CDC, Atlanta, GA.
12. Chien HP, Yu MC, Wu MH, Lin TP, Luh KT. 2000. Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int. J. Tuberc. Lung Dis. 4:866-870.
13. CLSI. 2008. Laboratory detection and identification of mycobacteria; approved guideline. CLSI document 48-A. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Davis JL, et al. 2011. The clinical and public health impact of automated nucleic acid testing for tuberculosis evaluation in San Francisco. Am. J. Respir. Crit. Care Med. 183:A5314. http://ajrccm.atsjournals.org/search?submit= yes&fulltext=A5314&sendit=Enter&volume=183&issue= 1+MeetingAbstracts&flag=MTG-ABSTRACT-ARTICLE&journalcode=ajrccm.
15. Forget EJ, Menzies D. 2006. Anti-infectives - adverse reactions to first-line antituberculosis drugs. Expert Opin. Drug Saf. 5:231-249. (Pubitemid 43379622)
16. Gen-Probe. 2001. Amplified Mycobacterium Tuberculosis Direct Test package insert, p 1. Gen-Probe, San Diego, CA.
17. Kent P, Kubica G. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Atlanta, GA.
18. Metchock B. 1995. Evaluation of length of incubation of negative BACTEC 12B cultures. Meeting of the American Society for Microbiology, 21-25 May 1995, Washington, DC. http://www.newsrx.com/newsletters/TB-and-Outbreaks-Week/1995-07- 24/072495767124292TW.html.
19. Murray PR, et al (ed). 2007. Manual of clinical microbiology, 9th ed, vol 1. ASM Press, Washington, DC.
20. Parrish N, Dionne K, Sweeney A, Hedgepeth A, Carroll K. 2009. Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems. Diagn. Microbiol. Infect. Dis. 63:342-345.
21. Pfyffer G, Cieslak C, Welscher H, Kissling P, Rusch-Gerdes S. 1997. Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solid-culture systems. J. Clin. Microbiol. 35:2229-2234. (Pubitemid 27349787)
22. Piersimoni C, et al. 2001. Comparison of MB/BacT ALERT 3D system with radiometric BACTEC system and Lowenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study. J. Clin. Microbiol. 39:651-657. (Pubitemid 32150835)
23. Resi D, Gagliotti C, Moro ML. 2004. Side effects of antituberculosis therapy. Am. J. Respir. Crit. Care Med. 169:542.
24. Rishi S, Sinha P, Malhotra B, Pal N. 2007. A comparative study for the detection of Mycobacteria by BACTEC MGIT 960, Lowenstein Jensen media and direct AFB smear examination. Indian J. Med. Microbiol. 25:383-386.
25. Rohner P, Ninet B, Metral C, Emler S, Auckenthaler R. 1997. Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J. Clin. Microbiol. 35:3127-3131. (Pubitemid 27505732)
26. Saukkonen JJ, et al. 2006. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am. J. Respir. Crit. Care Med. 174:935-952. (Pubitemid 44564795)
27. Scarparo C, et al. 2002. Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens. Diagn. Microbiol. Infect. Dis. 44:157-161. (Pubitemid 35375809)
28. Sorlozano A, et al. 2009. Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples. J. Microbiol. Biotechnol. 19:1259-1264.
29. Spark RP, Fried ML. 1988. Negative BACTEC 460-TB cultures. How long to incubate? Am. J. Clin. Pathol. 90:213-215.
30. Tenover FC, et al. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770. (Pubitemid 23086511)
31. Tortoli E, et al. 1999. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J. Clin. Microbiol. 37:3578-3582. (Pubitemid 29491095)
32. Whyte T, Hanahoe B, Collins T, Corbett-Feeney G, Cormican M. 2000. Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3131-3132. (Pubitemid 30640619)
33. Williams-Bouyer N, Yorke R, Lee HI, Woods GL. 2000. Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria. J. Clin. Microbiol. 38:4167-4170. (Pubitemid 32233221)
34. World Health Organization Stop TB Department. 2009. Treatment of tuberculosis guidelines, 4th ed. World Health Organization, Geneva, Switzerland.
35. Yan JJ, et al. 2000. Comparison of the MB/BacT and BACTEC MGIT 960 system for recovery of mycobacteria from clinical specimens. Diagn. Microbiol. Infect. Dis. 37:25-30.
36. Yee D, et al. 2003. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am. J. Respir. Crit. Care Med. 167:1472-1477. (Pubitemid 37363354)